1.Ation mechanism of dihydroartemisinin combined with COX-2 inhibitor in S180 carcinoma
Jiali ZHANG ; Zeng WANG ; Beibei ZHUANG ; Huijun ZHOU
Chinese Pharmacological Bulletin 1987;0(03):-
Aim To observe the inhibitory effect of dihydroartemisinin combined with COX-2 inhibitor on S180 sarcoma and their possible antitumor mechanisms.Methods The ICR mice model of the subcutaneous transplanting tumor was established by S180 sarcoma to investigate the treatment effect of dihydroartemisinin and COX-2 inhibitor.Expressions of VEGF,COX-2 and CD31 in S180 sarcoma were detected and the amount of leukocyte was also observed.Results Dihydroartemisinin combined with COX-2 inhibitor could potently inhibit tumor growth and inflammation.The maximal antitumor rate reached 55.38%.The results of immunohistochemistry showed that COX-2 and VEGF protein expressions were weakened by dihydroartemisinin and COX-2 inhibitor,versus the control groups.Further,RT-PCR analysis showed that the expression of VEGF mRNA was also effectively decreased.Finally,a significant down-regulation effect of COX-2 and VEGF protein expression was observed.Conclusions Dihydroartemisinin combined with COX-2 inhibitor can significantly inhibit S180 tumor.The antitumor mechanism of these two drugs might be closely related to the effect of COX-2 and VEGF expression suppression.
2.Effect of Increasing Diffusion Gradient Direction Number on Diffusion Tensor Imaging Fiber Tracking in the Human Brain.
Xufeng YAO ; Tonggang YU ; Beibei LIANG ; Tian XIA ; Qinming HUANG ; Songlin ZHUANG
Korean Journal of Radiology 2015;16(2):410-418
OBJECTIVE: To assess the effects of varying the number of diffusion gradient directions (NDGDs) on diffusion tensor fiber tracking (FT) in human brain white matter using tract characteristics. MATERIALS AND METHODS: Twelve normal volunteers underwent diffusion tensor imaging (DTI) scanning with NDGDs of 6, 11, 15, 21, and 31 orientations. Three fiber tract groups, including the splenium of the corpus callosum (CC), the entire CC, and the full brain tract, were reconstructed by deterministic DTI-FT. Tract architecture was first qualitatively evaluated by visual observation. Six quantitative tract characteristics, including the number of fibers (NF), average length (AL), fractional anisotropy (FA), relative anisotropy (RA), mean diffusivity (MD), and volume ratio (VR) were measured for the splenium of the CC at the tract branch level, for the entire CC at tract level, and for the full brain tract at the whole brain level. Visual results and those of NF, AL, FA, RA, MD, and VR were compared among the five different NDGDs. RESULTS: The DTI-FT with NDGD of 11, 15, 21, and 31 orientations gave better tracking results compared with NDGD of 6 after the visual evaluation. NF, FA, RA, MD, and VR values with NDGD of six were significantly greater (smallest p = 0.001 to largest p = 0.042) than those with four other NDGDs (11, 15, 21, or 31 orientations), whereas AL measured with NDGD of six was significantly smaller (smallest p = 0.001 to largest p = 0.041) than with four other NDGDs (11, 15, 21, or 31 orientations). No significant differences were observed in the results among the four NDGD groups of 11, 15, 21, and 31 directions (smallest p = 0.059 to largest p = 1.000). CONCLUSION: The main fiber tracts were detected with NDGD of six orientations; however, the use of larger NDGD (> or = 11 orientations) could provide improved tract characteristics at the expense of longer scanning time.
Adult
;
Anisotropy
;
Diffusion Tensor Imaging/*methods
;
Female
;
Humans
;
Male
;
White Matter/*radiography
;
Young Adult
3.Working Mode and Case Analysis of the First Pharmaceutical Ward Rounds in Our Hospital
Wei ZHUANG ; Suying YAN ; Xiaolan LIN ; Fei CHEN ; Li GAO ; Yingnan FENG ; Jing TANG ; Beibei JIA ; Yanqi CHU
China Pharmacy 2021;32(17):2129-2133
OBJECTIVE:To est ablish the working mode of the first pharmaceutical ward rounds of clinical pharmacists in our hospital,in order to provide a useful reference for establishing a national standardized pharmaceutical ward rounds model. METHODS:By sharing the clinical cases of the first pharmaceutical ward rounds ,the work content and process of the first pharmaceutical ward rounds in our hospital were introduced. RESULTS & CONCLUSIONS :The clinical pharmacist ’s first pharmaceutical ward round in our hospital mainly includes self introduction of clinical pharmacists ,diagnosis of patients ’condition under the guidance of doctors ,collection and evaluation of patients ’previous medication information (including previous medication varieties ,usage methods ,efficacy and safety evaluation ),assistance for doctors in formulating initial treatment plan , carrying out initial medication and diet education ,and intensive communication and cooperation with nurses. The development of first pharmaceutical ward rounds promotes the rational use of drugs in clinic ,elevates the hospitalization satisfaction of patients and improves the professional quality of clinical pharmacists.